RetourAFB
acid-fast bacilli
AHD
advanced HIV disease
AIDS
acquired immunodeficiency syndrome
ART
antiretroviral therapy
CAD
computer-aided detection
CFP-10
culture filtrate protein 10
CI
confidence interval
CRP
C-reactive protein
CSF
cerebrospinal fluid
CXR
chest X-ray
DR-TB
drug-resistant tuberculosis
DS-TB
drug-susceptible tuberculosis
ESAT-6
early secretory antigenic target 6 kDa protein
FDC
fixed-dose combination
GDF
Global Drug Facility
GI
gastrointestina
HIV
human immunodeficiency virus
HIVST
HIV self-testing
HMIS
health management information system
HTS
HIV testing services
IGRA
interferon-gamma release assay
IPT
isoniazid preventive treatment
IRIS
immune reconstitution inflammatory syndrome
LF-LAM
lateral flow lipoarabinomannan
LFT
liver function test
LTBI
latent tuberculosis infection
MDR-TB
multidrug-resistant tuberculosis
MTB
Mycobacterium tuberculosis
mWRD
molecular WHO-recommended rapid diagnostic test
NNRTI
non-nucleoside reverse transcriptase inhibitor
OAMT
opioid agonist maintenance therapy
PI
protease inhibitor
PLHIV
people living with HIV
PrEP
pre-exposure prophylaxis
PWUD
people who use drugs
QA
quality assurance
RR-TB
rifampacin-resistant tuberculosis
SOP
standard operating procedure
TB
tuberculosis
TBST
Mycobacterium tuberculosis antigen-based skin test
TPT
tuberculosis preventive treatment
TST
tuberculin skin test
W4SS
WHO-recommended four symptom screen
WHO
World Health Organization
XDR-TB
extensively drug-resistant tuberculosis
HIV medicines
3TC
lamivudine
ABC
abacavir
ATV
atazanavir
AZT
zidovudine
CPT
co-trimoxazole prophylactic therapy
DTG
dolutegravir
DRV
darunavir
EFV
efavirenz
FTC
emtricitabine
LPV
lopinavir
NVP
nevirapine
RAL
raltegravir
RTV
ritonavir
TAF
tenofovir alafenamide
TDF
tenofovir disoproxil fumarate
Tuberculosis medicines
B
bedaquiline
B6
pyridoxine
E
ethambutol
H
isoniazid
L
linezolid
M
moxifloxacin
P
rifapentine
Pa
pretomanid
R
rifampicin
Z
pyrazinamide